Vanderbilt University Medical Center: Study Finds Mark Cuban's Cost Plus Drug Company Could Save Taxpayers Millions on Medicare Generic Oncology Drugs
June 09, 2023
June 09, 2023
NASHVILLE, Tennessee, June 9 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
The U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company (MCCPDC), according to a study published today in the Journal of Clinical Oncology,
The Vanderbilt University Medical Center stu . . .
The U.S. government could save taxpayers between $228 million-$2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban Cost Plus Drug Company (MCCPDC), according to a study published today in the Journal of Clinical Oncology,
The Vanderbilt University Medical Center stu . . .